Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.89
Bid: 3.60
Ask: 4.18
Change: 0.00 (0.00%)
Spread: 0.58 (16.111%)
Open: 3.89
High: 0.00
Low: 0.00
Prev. Close: 3.89
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Snorkel Investment & Legal Proceeding Update

14 Oct 2022 13:17

RNS Number : 9849C
Tanfield Group PLC
14 October 2022
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Snorkel Investment & Legal Proceeding Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market on its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business, as well as with respect to additional loan subscriptions.

 

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights. 

 

· On 26 February 2021, Ward Hadaway was granted permission to join Foulston Siefkin, Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

 

Highlights

 

· The Company has agreed to settle its claim against Foulston Siefkin, the second defendant, in relation to the UK Proceedings on a no-fault basis for the sum of $4,500,000 including interest and costs (£3,978,903).

 

· Whilst the Company is no longer pursuing its claim against Foulston Siefkin in relation to the UK Proceedings, its claim against Ward Hadaway, the first defendant, continues with the 3-week trial scheduled to begin on 7 November 2022. 

 

· The US Proceedings are also continuing, with the jury trial currently expected to take place around the summer of 2023. 

 

 

Business Update

 

Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme, a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

Non-Fault Settlement

 

The Board is pleased to announce that the Company has reached an agreement to settle its claim against Foulston Siefkin, Tanfield's US based law firm at the time of the Contemplated Transaction, in relation to the UK Proceedings, on a no-fault basis for the sum of $4,500,000 including interest and costs (£3,978,903). For the avoidance of doubt, the agreed settlement should not be construed as an admission of liability or wrongdoing by Foulston Siefkin. Save as required under the AIM Rules for Companies, to which the Company remains subject, the terms of the settlement remain confidential between the parties.

 

UK & US Legal Proceedings

 

Whilst the Company is no longer pursuing its claim against Foulston Siefkin in relation to the UK Proceedings, its claim against Ward Hadaway, the solicitor acting for the Company at the time of the Contemplated Transaction, continues. The 3-week trial for the UK Proceedings is scheduled to begin on 7 November 2022.

 

Further to the update on 24 August 2022, the US Proceedings are continuing. Whilst there are ongoing deficiencies in the production of documents by Snorkel / Xtreme, the jury trial is currently still expected to take place around the summer of 2023.

 

The Board continues to believe that a positive outcome to either or both proceedings is possible. So far as it is necessary, the Company will continue to vigorously defend and advance its position in both proceedings, whilst continuing to seek advice.

 

Loan Instruments

 

As updated on 24 August 2022, the first loan note instrument has subscriptions totalling £625,000, the second loan note instrument has subscriptions totalling £950,000, and the third loan note instrument has subscriptions totalling £1,250,000. All of the loans are unsecured and carry annual interest of 10% which is to accrue and is repayable on the earlier of (i) 28 February 2025 or (ii) receipt of funds relating to either the US or UK Proceedings. Furthermore, should repayment take place prior to 28 February 2025, a 20% early redemption premium shall apply. 

 

As a consequence of the above settlement with Foulston Siefkin, the Board, with guidance from its legal advisors, will be assessing the level of funds required to complete the UK and US Proceedings. As required by the loan agreements, any excess funds will be used to repay a proportion of the loan note instruments.

 

The Board currently does not believe that further loans will be necessary to ensure that the Company can continue to protect its investment in Snorkel. 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Megan Liddell 020 7220 1666

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKQBDBBDDPKD
Date   Source Headline
26th Apr 20061:30 pmRNSPreliminary Results
13th Mar 20062:06 pmRNSResult of EGM
30th Jan 20063:36 pmRNSDirector/PDMR Shareholding
27th Jan 20067:01 amRNSTrading Update
4th Jan 20064:24 pmRNSHolding(s) in Company
4th Jan 20064:23 pmRNSHolding(s) in Company
21st Dec 20059:30 amRNSContract Wins
20th Dec 20054:36 pmRNSPlacing Update
19th Dec 20057:00 amRNSPlacing
1st Dec 20057:01 amRNSChina Joint Venture
24th Nov 20057:01 amRNSDistribution and New Product
9th Nov 20057:00 amRNSResult of EGM
18th Oct 20052:55 pmRNSDirector/PDMR Shareholding
14th Oct 20051:58 pmRNSDirector/PDMR Shareholding
5th Oct 20057:00 amRNSDairy Crest Contract Win
30th Sep 20057:00 amRNSInterim Results
29th Sep 20057:00 amRNSDairy Crest Contract
29th Jul 200510:12 amRNSDirector/PDMR Shareholding
19th Jul 200512:34 pmRNSDirector/PDMR Shareholding
13th Jul 20057:00 amRNSContract Win
29th Jun 200511:15 amRNSConversion of loan stock
21st Jun 200510:43 amRNSDirector Shareholding
15th Jun 20052:45 pmRNSDirector Shareholding
9th Jun 20054:29 pmRNSDirector Declaration
9th Jun 20057:00 amRNSAcquisition
20th May 200512:02 pmRNSResult of EGM
5th May 20057:00 amRNSStrategic Opportunities
28th Apr 20058:30 amRNSEGM Notice / Issue of Equity
20th Apr 20052:14 pmRNSHolding(s) in Company
4th Apr 20057:01 amRNSPreliminary Results
21st Mar 200512:27 pmRNSHolding(s) in Company
18th Mar 20053:12 pmRNSHolding(s) in Company
14th Mar 20057:00 amRNSMajor contract win
7th Mar 20057:00 amRNSRe Contract
1st Mar 20057:00 amRNSContract Wins
28th Feb 20057:00 amRNSMemorandum of Understanding
27th Jan 20057:00 amRNSTrading Statement
11th Jan 20054:45 pmRNSHolding(s) in Company
11th Jan 20054:39 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.